Active monitoring, radical prostatectomy, or radiotherapy for localised prostate cancer: study design and diagnostic and baseline results of the ProtecT randomised phase 3 trial

  • 0University of Bristol, Bristol, UK.

|

Summary

This summary is machine-generated.

Related Concept Videos